Literature DB >> 3792437

Comparative bioavailability and pharmacokinetics of noscapine hydrogen embonate and noscapine hydrochloride.

V Haikala, A Sothmann, M Marvola.   

Abstract

The relative bioavailability and pharmacokinetics of two orally administered aqueous suspensions of noscapine hydrogen embonate were compared with those of noscapine hydrochloride solution. Noscapine hydrochloride showed faster absorption and gave a higher peak concentration than the embonate. The average bioavailability of the embonates was 71% of that of the noscapine solution (p less than 0.05). No significant difference was observed when the embonate was administered with water, polyvidone and flavouring agents.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3792437     DOI: 10.1007/bf00981140

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  5 in total

1.  KBIOLOGICAL DISPOSITION OF NOSCAPINE. I. KINETICS OF METABOLISM, URINARY EXCRETION, AND ORGAN DISTRIBUTION.

Authors:  K P NAYAK; E BROCHMANN-HANSSEN; E L WAY
Journal:  J Pharm Sci       Date:  1965-02       Impact factor: 3.534

2.  Absorption and excretion of noscapine.

Authors:  S VEDSO
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1961

3.  New sensitive method to determine noscapine in serum by reversed-phase liquid chromatography.

Authors:  V Haikala
Journal:  J Chromatogr       Date:  1985-02-08

4.  Biphasic elimination of noscapine.

Authors:  M Gibaldi; N D Weiner
Journal:  J Pharm Sci       Date:  1966-08       Impact factor: 3.534

5.  Determination of noscapine in plasma by liquid chromatography.

Authors:  M Johansson; S Eksborg; A Arbin
Journal:  J Chromatogr       Date:  1983-07-08
  5 in total
  4 in total

1.  Pharmacokinetics of oral noscapine.

Authors:  M O Karlsson; B Dahlström; S A Eckernäs; M Johansson; A T Alm
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  Opium alkaloid noscapine is an antitumor agent that arrests metaphase and induces apoptosis in dividing cells.

Authors:  K Ye; Y Ke; N Keshava; J Shanks; J A Kapp; R R Tekmal; J Petros; H C Joshi
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

3.  Characterization of inhibition kinetics of (S)-warfarin hydroxylation by noscapine: implications in warfarin therapy.

Authors:  Nan Zhang; Ryan P Seguin; Kent L Kunze; Yan-Yan Zhang; Hyunyoung Jeong
Journal:  Drug Metab Dispos       Date:  2013-09-17       Impact factor: 3.922

4.  CYLD Regulates Noscapine Activity in Acute Lymphoblastic Leukemia via a Microtubule-Dependent Mechanism.

Authors:  Yunfan Yang; Jie Ran; Lei Sun; Xiaodong Sun; Youguang Luo; Bing Yan; Min Liu; Dengwen Li; Lei Zhang; Gang Bao; Jun Zhou
Journal:  Theranostics       Date:  2015-03-02       Impact factor: 11.556

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.